Specialty chemicals firm Anupam Rasayan files for IPO to raise Rs 760 crore

The proceeds will be used for repayment of debt, the firm said in the draft red herring prospectus (DRHP

IPO
Anupam Rasayan commenced operations in 1984 with conventional products, and now it makes speciality chemicals that involve multi-step synthesis and complex chemistries
Press Trust of India
1 min read Last Updated : Dec 24 2020 | 11:54 PM IST
Specialty chemicals company Anupam Rasayan has filed preliminary papers with Sebi to raise Rs 760 crore through an IPO.

The proceeds will be used for repayment of debt, the firm said in the draft red herring prospectus (DRHP). The Surat-based entity has decided to reserve a portion for its employees and may consider a discount for eligible staff.

Anupam Rasayan commenced operations in 1984 with conventional products, and now it makes speciality chemicals that involve multi-step synthesis and complex chemistries.

It has six multi-purpose manufacturing facilities in Gujarat with a combined aggregate installed capacity of around 23,396 tonnes, of which 6,726 tonnes was added in March 2020.

The company mainly caters to the agrochemical, personal care and pharmaceutical sectors, which accounted for over 95 per cent of its revenues in 2019-20. 

The company’s clients include Syngenta Asia Pacific, Sumitomo Chemical Company and UPL Limited. 

Axis Capital, Ambit Private, IIFL Securities and JM Financial have been appointed as merchant bankers for the issue.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :SEBISpecialty chemicalsinitial public offerings IPOs

Next Story